Markets:

Overview

News

Currencies

International

Treasuries

Mesoblast Limited - American Depositary Shares (NQ:MESO)

17.29 -0.57 (-3.19%)

Streaming Delayed Price Updated: 3:11 PM EDT, Jul 17, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Mesoblast Limited - American Depositary Shares

< Previous 1 2 3 4 5 6 7 8 Next >

Dow Dips 300 Points; Snap Shares Plunge ↗

February 01, 2023

U.S. stocks traded lower midway through trading, with the Dow Jones dropping over 300 points on Wednesday. The Dow traded down 0.91% to 33,774.70 while the NASDAQ fell 0.33% to 11,546.13. The S&P 500...

Via Benzinga

Silicon Laboratories, Credit Acceptance, Stryker And Other Big Stocks Moving Higher On Wednesday ↗

February 01, 2023

U.S. stocks traded lower, with the Dow Jones dropping over 200 points on Wednesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

US Stocks Open Lower; Dow Drops 125 Points ↗

February 01, 2023

U.S. stocks traded lower this morning, with the Dow Jones dropping around 125 points on Wednesday. Following the market opening Wednesday, the Dow traded down 0.37% to 33,960.34 while the NASDAQ fell...

Via Benzinga

Workday, XPeng, Titan Machinery And Some Other Big Stocks Moving Higher On Wednesday ↗

November 30, 2022

U.S. stocks traded lower, with the Dow Jones dropping over 200 points on Wednesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Short Volatility Alert: Mesoblast Limited ↗

July 21, 2022

On Wednesday, shares of Mesoblast Limited (NASDAQ: MESO) experienced volatile short activity. After the activity, the stock price went up +2.77% to $3.34. The overall sentiment for MESO has been...

Via Benzinga

Why Leslie's Shares Are Trading Lower By Over 9%? Here Are 60 Stocks Moving In Wednesday's Mid-Day Session ↗

November 30, 2022

Gainers Biophytis S.A. (NASDAQ: BPTS) shares jumped 114% to $0.7496. Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) rose 74.1% to $0.2115.

Via Benzinga

Mesoblast Lead Product Shows Durable Long-Term Survival At Four Years In Kids With Graft Versus Host Disease ↗

November 23, 2022

Via Benzinga

A Look At Some Of The Companies Innovating In the Cutting-Edge Regenerative Medicine Field

October 14, 2022

Biotechnology companies have broken many medical barriers in the past 40 years, harnessing the technological revolution to bring innovative solutions to medical problems.

Via TheNewswire.com

A Look At Some Of The Companies Innovating In the Cutting-Edge Regenerative Medicine Field

October 14, 2022

By David Willey, Benzinga

Via News Direct

A Look At Some Of The Companies Innovating In the Cutting-Edge Regenerative Medicine Field ↗

October 13, 2022

Biotechnology companies have broken many medical barriers in the past 40 years, harnessing the technological revolution to bring innovative solutions to medical problems.

Via Benzinga

October 04, 2022

Gainers LogicBio Therapeutics, Inc. (NASDAQ: LOGC) shares surged 637.6% to close at $2.01 on Monday after the company announced it will be acquired by AstraZeneca's subsidiary, Alexion, for $2.07 per...

Via Benzinga

Why Tesla Shares Are Trading Lower By Over 7%, Here Are 52 Stocks Moving In Monday's Mid-Day Session ↗

October 03, 2022

Gainers LogicBio Therapeutics, Inc. (NASDAQ: LOGC) gained 641% to $2.0207 after the company announced it will be acquired by AstraZeneca's subsidiary, Alexion, for $2.07 per share.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

July 19, 2022

We're starting off the day with a breakdown of the biggest pre-market stock movers investors will want to watch on Tuesday!

Via InvestorPlace

Benzinga's Top Ratings Upgrades, Downgrades For September 6, 2022 ↗

September 06, 2022

Upgrades

Via Benzinga

R&D Efforts for Alzheimer’s Therapies on the Rise with over 120 Drugs in Development

March 31, 2022

Palm Beach, FL – March 31, 2022 – FinancialNewsMedia.com News Commentary – Alzheimer’s disease (AD) is an irreversible, progressive neurodegenerative disease. It is the most common cause of dementia...

Via FinancialNewsMedia

87 Biggest Movers From Yesterday ↗

March 10, 2022

Gainers Sunshine Biopharma, Inc. (NASDAQ: SBFM) shares jumped 150% to close at $3.80 on Wednesday. Sunshine Biopharma, last month, priced its 1.88 million unit uplisting to...

Via Benzinga

50 Stocks Moving In Wednesday's Mid-Day Session ↗

March 09, 2022

Gainers Sunshine Biopharma, Inc. (NASDAQ: SBFM) rose 148% to $3.78. Sunshine Biopharma, last month, priced its 1.88 million unit uplisting to Nasdaq at $4.25 per unit. Direct...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

March 09, 2022

Gainers Sunshine Biopharma (NASDAQ:SBFM) stock rose 222.4% to $4.9 during Wednesday's pre-market session. The company's market cap stands at $21.9 million. TC...

Via Benzinga

Single Dose Of Mesoblast's Cell Therapy Shows Durable Reduction In Back Pain ↗

January 12, 2022

Mesoblast Limited (NASDAQ: MESO) announced 36-month follow-up results from the 400-subject Phase 3 trial of its allogeneic cell therapy rexlemestrocel-L in patients...

Via Benzinga

Alzheimer’s Disease Expected to Triple by 2050 While the Development Process for Potential Drug Candidates Increases

January 05, 2022

Palm Beach, FL – January 5, 2022 – FinancialNewsMedia.com News Commentary – Alzheimer’s disease (AD) is the most common reason of progressive dementia in the elderly population. There has been an...

Via FinancialNewsMedia

Topics Death

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

December 16, 2021

Gainers Calliditas Therapeutics (NASDAQ:CALT) stock rose 41.09% to $26.3 during Thursday's pre-market session. The market value of their outstanding shares is at $688....

Via Benzinga

FDA's Office Agrees On 12-Month Reduction In Pain As Primary Endpoint For Mesoblast's Back Pain Study ↗

December 16, 2021

Mesoblast Limited (NASDAQ: MESO) received feedback from the FDA's Office of Tissues and Advanced Therapies (OTAT) on the Phase 3 program of rexlemestrocel-L in...

Via Benzinga

The Daily Biotech Pulse: Calliditas Snags FDA Nod, Novartis to Buy Back $15B In Shares, Valneva Touts Vaccine Data, Immix, Bionomics Debut On Wall Street ↗

December 16, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Calliditas Gets Conditional Approval For Kidney Inflammation Disease Drug...

Via Benzinga

46 Biggest Movers From Yesterday ↗

December 16, 2021

Gainers Theseus Pharmaceuticals, Inc. (NASDAQ: THRX) gained 34.1% to settle at $12.58 on Wednesday. CMC Materials, Inc. (NASDAQ: CCMP) climbed 33.9% to close at $195.50 on...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

December 15, 2021

Gainers Biofrontera (NASDAQ:

Via Benzinga

36 Stocks Moving In Wednesday's Mid-Day Session ↗

December 15, 2021

Gainers Nxt-ID, Inc. (NASDAQ: NXTD) shares gained 28.9% to $3.21 after the company said it was awarded U.S. General Services Administration contract to distribute personal...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

December 15, 2021

Gainers Gemini Therapeutics (NASDAQ:GMTX) shares moved upwards by 32.92% to $3.23 during Wednesday's pre-market session. The market value of their outstanding shares...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

December 15, 2021

We're at the halfway point of the week but there's no slowing down as we dive into the biggest pre-market stock movers for Wednesday!

Via InvestorPlace

20 Stocks Moving in Wednesday's Pre-Market Session ↗

December 15, 2021

Gainers Galera Therapeutics, Inc. (NASDAQ: GRTX) rose 17.7% to $3.18 in pre-market trading after BTIG upgraded the stock from Neutral to Buy and announced a $15 price target....

Via Benzinga

50 Biggest Movers From Yesterday ↗

December 15, 2021

Gainers Sidus Space, Inc. (NASDAQ: SIDU) shares jumped 143.8% to settle at $12.19 on Tuesday after the company priced its IPO at $5 per share, MIND Technology, Inc. (NASDAQ: MIND...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.